Analysis of drug resistance and RAPD genotyping of Enterobacter cloacae producing new β-lactamases

ZHOU Jian-dang,YUAN Hong,CHEN Ying,HUANG Zhi-jun,YANG Guo-ping
DOI: https://doi.org/10.13350/j.cjpb.2009.11.010
2009-01-01
Abstract:Objective To ascertain the status,drug resistance,and prevalence of Enterobacter cloacae infection in a hospital and to investigate the mechanisms of resistance and genotyping to produce new lactamases in E.cloacae.Methods The K-B method was used for antimicrobial susceptibility testing.Extended-spectrum β-lactamases(ESBLs) and AmpC β-lactamases were detected by a double disk test and three-dimensional extraction test.Genotyping was done using random amplified polymorphic DNA(RAPD).Results Of 60 strains of E.cloacae identified,23 produced ESBLs,32 produced AmpC β-lactamase,and 14 produced new β-lactamases.According to RAPD analysis,the collection of 60 E.cloacae strains was divided into 7 genotypes,of which 68.3% were typesⅠ,Ⅱ,and Ⅲ,and these types were the major epidemic strains.The strains of new ESBLs-producing were resistant to 11 common antibiotics at a rate of 21.3%-100%.Conclusion E.cloacae nosocomial infection showed a high level of drug resistance,and the drug resistance of different types of β-lactamase produced by E.cloacae to different antibiotics differed.The appearance and prevalence of E.cloacae producing new β-lactamases are important factors for why E.cloacae becomes multidrug-resistant and highly resistant.
What problem does this paper attempt to address?